@article{b5a3dba352a64c8ab580a8eca6b52dec,
title = "FIGO good practice recommendations on the importance of registry data for monitoring rates and health systems performance in prevention and management of preterm birth",
abstract = "FIGO calls for strengthening of health information systems for reproductive, maternal, newborn, and child health services, co-designed with users, to ensure the timely accessibility of actionable high-quality data for all stakeholders engaged in preventing and managing preterm birth consequences. FIGO calls for strengthening of investments and capacity for implementing digital registries and the continuity of reproductive, maternal, newborn, and child health services in line with WHO recommendations, and strengthening of the science of implementation and use of registries—from local quality improvement to big data exploration.",
keywords = "health systems strengthening, high-quality data, preterm birth, prevention, registry",
author = "{the FIGO Working Group for Preterm Birth} and Fr{\o}en, {J. Frederik} and Ana Bianchi and Moller, {Ann Beth} and Bo Jacobsson and Bo Jacobsson and Simpson, {Joe Leigh} and Jane Norman and William Grobman and Ana Bianchi and Stephen Munjanja and Gonz{\'a}lez, {Catalina Mar{\'i}a Valencia} and Ben Mol and Andrew Shennan",
note = "Funding Information: Bo Jacobbson reports research grants from Swedish Research Council, Norwegian Research Council, March of Dimes, Burroughs Wellcome Fund, and the US National Institute of Health; clinical diagnostic trials on NIPT with Ariosa (completed), Natera (ongoing), Vanadis (completed), and Hologic (ongoing) with expenditures reimbursed per patient; clinical probiotic studies with product provided by FukoPharma (ongoing, no funding), and BioGaia (ongoing; also provided a research grant for the specific study); collaboration in IMPACT study where Roche, Perkin Elmer, and Thermo Fisher provided reagents to PLGF analyses; coordination of scientific conferences and meetings with commercial partners such as NNFM 2015, ESPBC 2016, and a Nordic educational meeting about NIPT and pre‐eclampsia screening. Bo Jacobbson is also Chair of the FIGO Working Group for Preterm Birth and the European Association of Perinatal Medicine special interest group on preterm delivery; steering group member of Genomic Medicine Sweden; chairs the Genomic Medicine Sweden complex diseases group; and is Swedish representative in the Nordic Society of Precision Medicine. All other named authors report no conflicts of interest. Funding Information: This work has been supported by grants from March of Dimes. Publisher Copyright: {\textcopyright} 2021 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.",
year = "2021",
month = oct,
doi = "10.1002/ijgo.13847",
language = "English (US)",
volume = "155",
pages = "5--7",
journal = "International Journal of Gynecology and Obstetrics",
issn = "0020-7292",
publisher = "Elsevier Ireland Ltd",
number = "1",
}